KBC Group’s NPS PHARMACEUTICALS INC NPSP Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2015
Q1
Sell
-31,296
Closed -$1.12M 1483
2014
Q4
$1.12M Buy
31,296
+20,193
+182% +$603K 0.01% 730
2014
Q3
$289K Sell
11,103
-29,970
-73% -$861K 0.01% 883
2014
Q2
$1.36M Sell
41,073
-80,403
-66% -$2.32M 0.02% 685
2014
Q1
$3.64M Buy
121,476
+40,306
+50% +$1.39M 0.06% 361
2013
Q4
$2.46M Buy
81,170
+14,465
+22% +$398K 0.04% 461
2013
Q3
$2.12M Buy
66,705
+34,573
+108% +$793K 0.03% 490
2013
Q2
$486K Buy
+32,132
New +$445K 0.01% 821

Other funds holding NPSP

KBC Group's NPSP Position: Q1 2015 in Review

KBC Group sold out of NPS PHARMACEUTICALS INC (NPSP) in Q1 2015, closing a stake of 31,296 shares — an estimated $1.12M sold.

KBC Group first reported a position in NPSP in Q2 2013 and held it in 7 quarters. The position peaked at $3.64M in Q1 2014. 1 fund tracked by Wall St. Rank holds NPSP as of Q1 2015.

  • KBC Group reported no remaining NPS PHARMACEUTICALS INC position as of Q1 2015 after selling out during the quarter.
  • KBC Group sold 31,296 NPS PHARMACEUTICALS INC shares in Q1 2015, an estimated $1.12M.
  • KBC Group first reported a position in NPS PHARMACEUTICALS INC in Q2 2013 and held it in 7 quarters.
  • KBC Group's NPS PHARMACEUTICALS INC position peaked at $3.64M in Q1 2014.
  • 1 fund tracked by Wall St. Rank held NPS PHARMACEUTICALS INC as of Q1 2015.

Based on KBC Group's 13F filing for Q1 2015, filed 30 Apr 2015.